Trial intelligence / Profile preview

Mesalazine in patients with colonic adenoma

2012-001351-40Phase 2Completed

Sponsor
SOFAR
Start
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of Salcrozine in colon adenoma, sponsored by SOFAR. Started Aug 2012; status: completed.

02

Drugs

Salcrozine
03

Conditions

colon adenoma

Beyond the preview

Go deeper on 2012-001351-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001351-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call